- ≥99% HPLC purity
- Lot-matched certificate of analysis
- Ships next business day, tracked
Phenylpiracetam
Phenylated racetam (fonturacetam), 100 mg capsules, 30 per bottle
- FormPowder-filled hard capsule, sealed bottle
- Mol. weight218.25 g/mol
- Research areasCognition and memory models, locomotor activity, stress adaptation, comparative racetam pharmacology
Supplied for laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease.
Overview
Phenylpiracetam is a small-molecule member of the racetam family, formed by adding a phenyl group to the pyrrolidone ring of piracetam. It is also encountered in the literature as fonturacetam and, in the older Soviet-era sources, as carphedon. The phenyl substitution changes the molecule's lipophilicity considerably relative to the parent compound, and that single structural difference is the starting point for most of the comparative pharmacology written about it.
The compound was developed in the Soviet Union and remains registered as a medicine in a small number of post-Soviet states; it has never been approved as a drug in the United States, and it is not a dietary supplement or food ingredient under US law. It carries a chiral centre, so it exists as R- and S-enantiomers with reported differences in activity, and racemic material is the form usually described in the literature and supplied for research.
Specifications
Identity
- CAS number
- 77472-70-9
- Molecular formula
- C12H14N2O2
- Molecular weight
- 218.25 g/mol
Supply & purity
- Form
- Powder-filled hard capsule, sealed bottle
- Available sizes
- 100 mg × 30 capsules
Additional detail
- Compound class
- Racetam; 2-oxo-pyrrolidine acetamide derivative
- Also known as
- Fonturacetam, carphedon, phenotropil
- Structural relationship
- Piracetam bearing a phenyl group at the 4-position of the pyrrolidone ring
- Stereochemistry
- One chiral centre; supplied as the racemate
- Appearance
- White to off-white crystalline powder within the capsule
- Research areas
- Cognition and memory models, locomotor activity, stress adaptation, comparative racetam pharmacology
- Storage
- Cool, dry conditions in the sealed bottle, away from light and humidity
Questions about Phenylpiracetam
How does phenylpiracetam differ from piracetam?
Structurally it is piracetam carrying a phenyl group on the pyrrolidone ring. That substitution markedly increases lipophilicity, and comparative animal studies were designed largely to ask what that structural change does to distribution and behavioural endpoints relative to the parent compound.
Is it a peptide?
No. Phenylpiracetam is a small organic molecule of 218.25 g/mol with no amino acid residues, which is why it sits in the research-compounds department rather than among the peptides. It does appear alongside peptide nootropics such as semax and selank in comparative studies.
Is documentation available for the material?
Yes. Each lot is analysed by HPLC for identity and purity and a lot-matched certificate of analysis is available on request. Quote the lot number printed on the bottle when requesting the document, and record it alongside your results.
What is its regulatory status in the United States?
It has never been approved as a drug by the FDA and it does not qualify as a dietary supplement ingredient. It also appears on the WADA Prohibited List as a stimulant. It is therefore handled strictly as a research chemical, with no permitted consumer use.
Can these capsules be taken?
No. Despite the familiar capsule format, this is a research article supplied for laboratory investigation only. It is not food, medicine or a supplement, it is not approved for human or veterinary administration, and it must not be resold for consumption.
Related
